Pay in 4 interest-free payments of $6.97 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Novo Nordisks semaglutide, marketed as Wegovy for people with obesity and Ozempic for those with Type 2 diabetes, has been on the FDA Drug Shortages list since August 2022
Retatrutide falls into this same range
The Ozempic effect is finally showing up in obesity data The decline of one of Americas biggest health crises, in two charts
Kickstart your weight loss journey with Wegovy, a groundbreaking weight loss injection that mimics the GLP-1 hormone to help control cravings, delay stomach emptying, and keep you feeling fuller for longer
US$ 27.47
US$ 28.07
US$ 26.42
US$ 21.13
US$ 26.28
US$ 21.95
US$ 27.99
US$ 21.54
US$ 23.90
